Journal ArticleOPEN ACCESS

Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies

Clinical Infectious Diseases (2000) 31(3) 821-822
DOI: 10.1086/314023
16Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A total of 21 patients with hematologic malignancies were given thiabendazole for treatment of strongyloidiasis. Fifteen patients were cured. Since there were no relapses, it is unlikely that maintenance therapy has a role in the management of strongyloidiasis in this population of patients.

Cite

CITATION STYLE

APA

Schaffel, R., Nucci, M., Portugal, R., Castro, M. B., Ferreira, S. B., Almeida, L., … Pulcheri, W. (2000). Thiabendazole for the treatment of strongyloidiasis in patients with hematologic malignancies. Clinical Infectious Diseases, 31(3), 821–822. https://doi.org/10.1086/314023

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free